Pharmaceuticals

Non-Therapeutic Biomolecules Industry Forecast Indicating Market Size of $56.43 Billion by 2030 at 10.7% CAGR

March 23, 2026March 24, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Is The Market Size Of The Non-Therapeutic Biomolecules Market Expected To Change Between 2026 And 2030?

The non-therapeutic biomolecules market size has seen rapid growth in recent years. This market is forecasted to expand from $33.92 billion in 2025 to $37.59 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.8%. The historical expansion of the market is attributable to several factors, including the rising demand for research biomolecules, increasing adoption in in vitro diagnostics, growth within pharmaceutical research, advancements in recombinant protein technology, and a surge in collaborations between biotech firms.

The non-therapeutic biomolecules market size is projected to undergo significant expansion over the next few years. It is forecast to reach $56.43 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.7%. This anticipated growth during the forecast period is driven by the expansion of synthetic biomolecule applications, increasing investment in precision medicine, greater utilization in agricultural biotechnology, a growing emphasis on sustainable and scalable biomolecule production, and advancements in automated biomolecule synthesis platforms. Prominent trends expected within this period encompass advanced protein engineering, high-throughput screening technologies, sustainable biomolecule production, cell-free biomolecule synthesis, and customizable biomolecule platforms.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8769&type=smp

What Underlying Factors Are Accelerating The Growth Of The Non-Therapeutic Biomolecules Market?

The future expansion of the non-therapeutic biomolecules market is anticipated to be driven by the escalating volume of research and laboratory testing. Laboratory testing is defined as a medical procedure that examines samples such as blood, urine, or other bodily substances to identify and monitor diseases and formulate treatment strategies, while research involves generating novel knowledge or creatively applying existing knowledge to develop new ideas, theories, and insights. In laboratory assays, non-therapeutic biomolecules are employed to gauge the existence or concentration of biomarker molecules indicative of illness, thereby improving the sensitivity and specificity of such tests. For instance, in July 2024, according to the National Health Service (NHS), a UK-based hospital and health care provider, diagnostic activity exceeded pre-pandemic levels in 2023, with a 21% increase in tests performed in May 2024 compared to 2023. Consequently, the rising instances of research and laboratory testing are fueling the growth of the non-therapeutic biomolecules market.

How Is The Non-Therapeutic Biomolecules Market Structured Across Different Segments?

The non-therapeutic biomolecules market covered in this report is segmented –

1) By Trad Pharma: Enzymes, Recombinant Proteins, Plasmids, Peptides, Oligonucleotides, Monoclonal Antibodies

2) By End User: Research, Pharma, In Vitro Diagnostics(IVD)

3) By Application: Diagnostic Equipment, Therapeutic Equipment, Monitoring Or Imaging Equipment, Laboratory Or Research Equipment, Rehabilitation Or Mobility Support

Subsegments:

1) By Enzymes: Industrial Enzymes, Diagnostic Enzymes

2) By Recombinant Proteins: Antigens, Cytokines, Growth Factors

3) By Plasmids: Research Plasmids, Expression Plasmids

4) By Peptides: Antimicrobial Peptides, Signaling Peptides

5) By Oligonucleotides: Antisense Oligonucleotides, RNAi Oligonucleotides

6) By Monoclonal Antibodies: Research Antibodies, Diagnostic Antibodies

Which Trends Are Shaping The Future Of The Non-Therapeutic Biomolecules Market?

Leading companies in the non-therapeutic biomolecules market are concentrating on advancing novel cell separation technology to enhance throughput and streamline processes, thereby securing a competitive advantage within the market. This cutting-edge, research-focused kit is designed to furnish scientists with an essential remedy for difficulties encountered in biological and laboratory workflows. As an illustration, in May 2023, AcouSort AB, a biotechnology firm based in Sweden, introduced the AcouTrap 3 system. The system merges the distinct characteristics of acoustofluidics, integrating sound waves with microfluidics, to present an efficient method for isolating cells and extracellular vesicles within a singular workflow. The AcouTrap 3 system utilizes gentle acoustic trapping technology, enabling researchers to process a greater number of samples with improved cell viability and reduced loss when contrasted with traditional column- or bead-based approaches, consequently boosting productivity and refining laboratory procedures.

Which Major Players Dominate The Non-Therapeutic Biomolecules Market?

Major companies operating in the non-therapeutic biomolecules market are Amgen Inc., Genentech Inc., Merck KGaA, Lonza Group AG, Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Charles River Laboratories International Inc., GE Healthcare Life Sciences, Fujifilm Diosynth Biotechnologies, Evonik Industries AG, Seikagaku Corporation, Takeda Pharmaceutical Company Limited, MilliporeSigma, Covance Inc., Sartorius AG, Sanofi S.A., CordenPharma International, Bayer AG, WuXi AppTec, Ginkgo Bioworks, Eppendorf AG, Bio-Techne Corporation, Vectalys, Avid Bioservices Inc.

Read the full non-therapeutic biomolecules market report here:

https://www.thebusinessresearchcompany.com/report/non-therapeutic-biomolecules-global-market-report

Which Region Is Projected To Dominate The Non-Therapeutic Biomolecules Market During The Forecast Period?

Asia-Pacific was the largest region in the non-therapeutic biomolecules market share in 2025. The regions covered in the non-therapeutic biomolecules market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Non-Therapeutic Biomolecules Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=8769&type=smp

Browse Through More Reports Similar to the Global Non-Therapeutic Biomolecules Market 2026, By The Business Research Company

Non Therapeutic Biomolecules Market Report 2026

https://www.thebusinessresearchcompany.com/report/non-therapeutic-biomolecules-global-market-report

Peptide Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/peptide-therapeutics-global-market-report

Bioengineered Protein Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/bioengineered-protein-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795